You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 14 Humanized TFR1/CD71 knockin mouse model enables in vivo assessment of TFR1-targeted antibody therapies for cancer and beyond to across the blood-brain barrier

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
14 Humanized TFR1/CD71 knockin mouse model enables in vivo assessment of TFR1-targeted antibody therapies for cancer and beyond to across the blood-brain barrier

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023184018
Dec 2023101016
Jan 202426406
Feb 20247008
Mar 2024110013
Apr 2024108013
May 20246403
Jun 2024112013
Jul 20247409
Aug 202484015
Sep 202488011
Oct 2024114014
Nov 2024136049
Dec 2024110016
Jan 2025154023
Feb 202548024
Mar 20250012
Apr 20250020
May 20250021
Jun 2025008
Total18210312